Parkman Healthcare Partners’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-96,837
| Closed | -$569K | – | 104 |
|
|
2023
Q4 | $569K | Sell |
96,837
-96,800
| -50% | -$569K | 0.08% | 86 |
|
|
2023
Q3 | $1.89M | Buy |
193,637
+7,855
| +4% | +$76.6K | 0.35% | 78 |
|
|
2023
Q2 | $2.2M | Buy |
185,782
+3,886
| +2% | +$46K | 0.38% | 73 |
|
|
2023
Q1 | $1.96M | Buy |
181,896
+40,314
| +28% | +$435K | 0.43% | 57 |
|
|
2022
Q4 | $1.64M | Sell |
141,582
-95,115
| -40% | -$1.1M | 0.44% | 61 |
|
|
2022
Q3 | $3.53M | Sell |
236,697
-52,053
| -18% | -$777K | 1% | 37 |
|
|
2022
Q2 | $2.61M | Buy |
+288,750
| New | +$2.61M | 0.96% | 36 |
|